sacituzumab,Sacituzumab
gilead sciences
['sacitu, govi', 'bcsm', 'sacituzumab', 'breast']
sacituzumab govitecan significantly prolongs overall survival in patients with hr+/her2- metastatic breast cancer #bcsm #oncology #nursing #bcsm #breastcancer #esmo22 
Your online destination for Oncology Nursing news, clinical insights, and resources.